ReviewMagnetic resonance in medicine2026
Steps on the Path to Clinical Translation-A British and Irish Chapter ISMRM Workshop Survey of the UK MRI Community.
Review in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Steps on the Path to Clinical Translation-A British and Irish Chapter ISMRM Workshop Survey of the UK MRI Community.Magnetic resonance in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our goal was to understand the barriers and challenges to clinical translation of quantitative MR (qMR) as perceived by stakeholders in the UK. We conducted an electronic survey on seven key areas related to clinical translation of qMR, developed at the BIC-ISMRM workshop: "Steps on the path to clinical translation". Based on the seven areas identified: (i) clinical workflow, (ii) changes in clinical practice, (iii) improving validation, (iv) standardization of data acquisition and analysis, (v) sharing of data and code, (vi) improving quality management, and (vii) end-user engagement, a 40-question survey was developed. Members of BIC-ISMRM, MR-PHYSICS, BSNR and institutional mailing lists were invited to respond to the online survey over a 5-week period between September and October 2022. The responses were analysed via descriptive statistics of multiple-choice questions, Likert scores and a thematic analysis of free text questions. A total of 69 responses were received from predominantly research imaging scientists (69%) in numerous centres across the UK. Three main themes were identified: (1) Consensus; the need to develop in terminology, decision making and validation; (2) Context Dependency; an appreciation of the uniqueness of each clinical situation, and (3) Product Profile; a clear description of the imaging biomarker and its intended use. Effective translation of qMR imaging and spectroscopic biomarkers to achieve their full clinical potential must address the differing needs and expectations of a wide range of stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.